25 November 2016

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology makes the following update on its block listing, pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies. All figures relate to options over ordinary shares of 0.2 pence each.

The table below provides further detail.

Name of company: Futura Medical plc
Name of scheme: Unapproved Share Option Scheme ("USOS")

EMI Share Option Scheme ("EMI")
Period of return: From: 20 May 2016
To: 24 November 2016
Number and class of securities not issued under the scheme(s) USOS: 1,440,600
EMI: 1,344,141
Total: 2,784,741
Number of securities issued under the scheme(s) during the period

Number of securities lapsed under the scheme(s) during the period (EMI adjustment to May return)


Balance under the scheme(s) of securities not yet issued at the end of the period USOS: 1,156,321
EMI: 1,364,141
Total: 2,520,462
Number and class of securities originally admitted and the date of admission USOS: 814,424 on 25 May 2011 and 1,202,280 on 8 October 2013
USOS Total: 2,016,704
EMI: 1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013
EMI Total: 2,988,296
  Total: 5,005,000
Name of contact: Derek Martin, Chief Financial Officer
Telephone number of contact: +44 (0) 1483 685 670


For further information please contact:

Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
+44 (0) 1483 685 670

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Mark Court / Sophie Wills /
Stephanie Watson / Tilly Abraham
Tel: +44 (0) 20 7466 5000